Reason for request
Inclusion on the list of medicines reimbursed by National Health Insurance and approved for hospital use.
Clinical Benefit
| Insufficient |
In the current state of the dossier and while awaiting the results of the VEG 108844 non-inferiority study comparing VOTRIENT with sunitinib, the Transparency Committee considers that the actual benefit is insufficient to justify reimbursement by National Health Insurance. |
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
tdPSMD4Pn01EEW0p
